Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.
about
Update on autoimmune hepatitisHLA and cell-mediated immunity in HBsAg negative chronic active hepatitisAuto immune hepatitisUpdate on Autoimmune HepatitisHepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcomeCirrhosis and autoimmune liver disease: Current understandingAutoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristicsManagement and outcome of pregnancy in autoimmune hepatitis'Relapse' of chronic active hepatitis--not always what it seemsNon-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.Long-term treatment outcomes for autoimmune hepatitis in Korea.Treatment of autoimmune hepatitis.Management of Difficult Cases of Autoimmune HepatitisDifficult treatment decisions in autoimmune hepatitis.Juvenile autoimmune hepatitis: Spectrum of the disease.Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.Abnormal aminopyrine metabolism in patients with chronic hepatitisHormone replacement therapy in chronic active hepatitis; a case report.Current status of therapy in autoimmune liver diseaseChronic active hepatitis.Immunological aspects of liver disease.Influence of azathioprine on hepatic reserve in chronic active liver diseaseContrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.Lymphocyte cytotoxicity in chronic active hepatitis: effect of therapy and correlations with clinical and histological changes.Oral prednisone for chronic active liver disease: dose responses and bioavailability studies.Corticosteroids in liver disease: possible mechanisms of action, pharmacology, and rational use.Chronic hepatitis.Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.Cell-mediated immunity in acute and chronic hepatitis.Chronic hepatitis in the 1980s.Hepatocellular carcinoma in HBsAg-negative chronic active hepatitis.Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitisTacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trialEffect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.Autoimmune acute liver failure: proposed clinical and histological criteria.Lymphocyte cytotoxicity to autologous liver cells in chronic active hepatitis.Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis.The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.Dangers of immunosuppressive therapy in hepatitis B virus carriers.Access to primary care is associated with better autoimmune hepatitis outcomes in an urban county hospital
P2860
Q22305505-A743FD96-B9D3-40A0-A0E0-28F7A7DA773BQ24541422-21F1BE1D-8F0E-4440-819A-0B6125FCFCA6Q26746242-BC62BF88-6C58-426E-AE7E-8C128F726D60Q26781765-05613901-B04C-4067-B99A-CF548E7DDDA5Q26859121-C4BCFA43-4A09-4A89-B6F9-45CF55655B26Q28070154-A735BB98-DC2F-406F-B73B-00EAD836ECB6Q28087726-BFB0E931-B5BF-4347-9798-F8DAA6507288Q28345133-FB5AAE92-3110-4F16-9EC1-0CFD89E0EA3DQ28379330-083BD3CD-A53D-4C5F-9A50-F6459B15776EQ33447479-685BA283-3CFE-41A5-81E0-E24A2F81AF97Q33565469-E16536E8-15A0-4E00-A8DB-5D559994BE5DQ33618244-F055E8F5-F466-470C-B724-B4CDC49DFB65Q33619600-044D109F-F31F-45C7-A45C-24E9B4AE635DQ33688293-5D6D9B6B-521D-4FE4-B27D-50CE88DB7913Q33948215-306E7943-01B8-4BEE-B26B-512887886D00Q34069579-EF466BC8-19A2-49B9-9BA7-64EF42AD3F07Q34109570-1E28B877-D593-4307-AC56-3D327CB5CC44Q34377693-1EDB4E27-9C6D-4A66-B336-4CF67D430088Q34408950-52C9BB3D-B38E-4E98-B031-B365FC0F6E87Q34460416-285A9DB7-F94B-4783-9930-AA5C4B33F507Q34460439-605F0FE0-66DF-4F4E-AED4-D298B3D3CCE5Q34471469-131A82B4-9B1C-4977-A249-AD7BA46764FEQ34472161-8A5D6BC9-329D-437E-B26A-BFCEE1283A07Q34474161-A40874B4-E23D-4253-AE73-BFC24CA7105AQ34475234-A40345D2-B8C0-4B03-B024-AEAFA75669F0Q34476557-4DFA4AC7-059C-4CE6-AE7E-01FE878CE543Q34476917-7A64F171-45EA-4826-A2A6-543B12603775Q34477263-A6B3EC01-D5DE-44C0-BD5E-F2AA408BF483Q34477828-DDFAC576-2BEE-40E8-ADBC-063536486DE2Q34489309-8D8F6B16-10DE-4C50-AEC8-2BAE06D9AE77Q34493444-128B31C9-1AC5-4857-9D5C-B5BF4693E960Q34494662-7861BFF1-D6AC-4DA4-A90E-D32A5EAA5447Q34498312-A5B68790-3195-42A7-84E5-2436375A045EQ34527365-98C2EF2C-2460-4357-B865-1EC6065092A4Q34822608-7EFC9850-A089-45AF-9CC5-FDC16E3369D9Q35075223-6E9E1D36-3CDD-4AB9-8126-85BBF5680252Q35126088-99CC0656-629A-4E45-AB6B-401746E141FFQ35341829-8B6A7913-08E0-45BC-A06C-C01683D98284Q35367946-57B2FD6E-330C-4DA4-8ABC-05237F28F9F3Q35716890-47E794D2-9D25-4A21-A00C-5ACDEDD919B3
P2860
Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh
1972年學術文章
@zh-hant
name
Clinical, biochemical, and his ...... reatments and early prognosis.
@en
Clinical, biochemical, and his ...... reatments and early prognosis.
@nl
type
label
Clinical, biochemical, and his ...... reatments and early prognosis.
@en
Clinical, biochemical, and his ...... reatments and early prognosis.
@nl
prefLabel
Clinical, biochemical, and his ...... reatments and early prognosis.
@en
Clinical, biochemical, and his ...... reatments and early prognosis.
@nl
P2093
P1433
P1476
Clinical, biochemical, and his ...... reatments and early prognosis.
@en
P2093
Baggenstoss AH
Elveback IR
Gitnićk GL
Schoenfield LJ
Soloway RD
Summerskill WH
P304
P407
P577
1972-11-01T00:00:00Z